UBS O'Connor’s Ascendis Pharma A/S ASND Stock Holding History

UBS O'Connor’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,228	Closed	-$177K	–	747
2015 Q1	$177K	Buy	+10,228	New	+$186K	﹤0.01%	679

Other funds holding ASND

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

UBS O'Connor's ASND Position: Q2 2015 in Review

UBS O'Connor sold out of Ascendis Pharma A/S (ASND) in Q2 2015, closing a stake of 10,228 shares — an estimated $177K sold.

UBS O'Connor first reported a position in ASND in Q1 2015 and held it in 1 quarter. The position peaked at $177K in Q1 2015. 33 funds tracked by Wall St. Rank hold ASND as of Q2 2015.

UBS O'Connor reported no remaining Ascendis Pharma A/S position as of Q2 2015 after selling out during the quarter.
UBS O'Connor sold 10,228 Ascendis Pharma A/S shares in Q2 2015, an estimated $177K.
UBS O'Connor first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 1 quarter.
UBS O'Connor's Ascendis Pharma A/S position peaked at $177K in Q1 2015.
33 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.